Opko Health Stock Alpha and Beta Analysis
| OPK Stock | USD 1.54 0.04 2.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Opko Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Opko Health over a specified time horizon. Remember, high Opko Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Opko Health's market risk premium analysis include:
Beta 0.6 | Alpha (0.16) | Risk 2.39 | Sharpe Ratio (0.02) | Expected Return (0.05) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Opko |
Opko Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Opko Health market risk premium is the additional return an investor will receive from holding Opko Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Opko Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Opko Health's performance over market.| α | -0.16 | β | 0.60 |
Opko Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Opko Health's Buy-and-hold return. Our buy-and-hold chart shows how Opko Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Opko Health Market Price Analysis
Market price analysis indicators help investors to evaluate how Opko Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Opko Health shares will generate the highest return on investment. By understating and applying Opko Health stock market price indicators, traders can identify Opko Health position entry and exit signals to maximize returns.
Opko Health Return and Market Media
The median price of Opko Health for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 1.52 with a coefficient of variation of 4.43. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 1.54, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Barrington Research Reaffirms Outperform Rating for OPKO Health | 09/24/2024 |
2 | Acquisition by Phillip Frost of tradable shares of Opko Health at 1.15 subject to Rule 16b-3 | 09/27/2024 |
3 | Acquisition by Rubin Steven D of 10000 shares of Opko Health at 1.3 subject to Rule 16b-3 | 10/22/2024 |
4 | OPKO Health, Inc.s CEO Phillip Frost is the most upbeat insider, and their holdings increased by 9.6 percent last week | 10/30/2024 |
5 | OPKO Health Q3 Earnings Preview | 11/06/2024 |
6 | OPKO Health Inc Q3 2024 Earnings EPS of 0.04 Beats Estimates, Revenue of 173. ... | 11/07/2024 |
7 | Opko Health earnings beat by 0.12, revenue fell short of estimates | 11/08/2024 |
8 | Acquisition by Phillip Frost of 14800 shares of Opko Health at 1.78 subject to Rule 16b-3 | 11/12/2024 |
9 | Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.6198 subject to Rule 16b-3 | 11/14/2024 |
10 | NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health Nutrition Expo | 11/18/2024 |
11 | Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.59 subject to Rule 16b-3 | 11/22/2024 |
12 | Acquisition by Phillip Frost of 199072 shares of Opko Health at 1.534 subject to Rule 16b-3 | 11/29/2024 |
About Opko Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Opko or other stocks. Alpha measures the amount that position in Opko Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.001157 | 0.001099 | Price To Sales Ratio | 1.31 | 1.25 |
Opko Health Upcoming Company Events
As portrayed in its financial statements, the presentation of Opko Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Opko Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Opko Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Opko Health. Please utilize our Beneish M Score to check the likelihood of Opko Health's management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Opko Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Opko Health Backtesting, Opko Health Valuation, Opko Health Correlation, Opko Health Hype Analysis, Opko Health Volatility, Opko Health History and analyze Opko Health Performance. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Opko Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.